Health Care: Drugs

Theravance Inc (THRX: NASDAQ)

$16.59 n/a | n/a%
03/26/15 - 04:00 PM ET
Company Income Statement
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Sales 8.43M 4.76M 135.76M 24.51M
Cost of Sales 0.00 0.00 0.00 0.00
Gross Operating Profit 8.43M 4.76M 135.76M 24.51M
Selling, General, and Administrative Expenses 34.86M 48.44M 30.86M 30.68M
Research & Development 7.50M 125.18M 117.90M 103.57M
Operating Income before D & A (EBITDA) -33.93M -168.86M -13.00M -109.74M
Depreciation & Amortization 16.32M 8.20M 7.33M 7.58M
Interest Income 563.00K 778.00K 460.00K 415.00K
Other Income - Net -3.27M 6.73M 0.00 0.00
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -52.96M -169.56M -19.86M -116.90M
Interest Expense 36.89M 9.35M 6.00M 6.02M
Pre-Tax Income -89.86M -178.90M -25.87M -122.93M
Income Taxes 0.00 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -73.53M -170.70M -18.54M -115.34M
Net Income From Discontinued Operations -94.93M 0.00 0.00 0.00
Net Income From Total Operations -168.46M -170.70M -18.54M -115.34M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -168.46M -170.70M -18.54M -115.34M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-73.53M -170.70M -18.54M -115.34M
Preferred Dividends
Net Income Available To Common -73.53M -170.70M -18.54M -115.34M
Basic EPS from Continuing Ops. -0.66 -1.67 -0.20 -1.41
Basic EPS from Discontinued Ops. -0.84 0.00 0.00 0.00
Basic EPS from Total Operations -1.50 -1.67 -0.20 -1.41
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -1.50 -1.67 -0.20 -1.41
Basic Normalized Net Income/Share -0.66 -1.67 -0.20 -1.41
EPS fr Continuing Ops. -0.66 -1.67 -0.20 -1.41
EPS fr Discontinued Ops -0.84 0.00 0.00 0.00
EPS fr Total Ops. -1.50 -1.67 -0.20 -1.41
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -1.50 -1.67 -0.20 -1.41
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.66 -1.67 -0.20 -1.41
Dividends Paid per Share 0.50 0.00 0.00 0.00

Portfolios with THRX

Latest THRX Headlines from TheStreet

More Financial News for THRX

Press Releases for THRX

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter